Monopar Therapeutics director Raymond Anderson sells USD 349,125 of common shares
MNPR•Director sale lowers Monopar Therapeutics stake
- Director Raymond Anderson sold 3,142 Monopar Therapeutics common shares on Aug. 25, 2026 at prices around USD 110.04 to USD 113.05.
- Holdings fell to 23,751 shares following the sales.
